1399 - Percutaneous Tibial Nerve Stimulation administered through the Urgent PC Neuromodulation

Page last updated: 14 February 2017

Application Detail

Status

Open

Description of Medical Service

Percutaneous Tibial Nerve Stimulation is administered through an Urgent PC Neuromodulation System. The system treats overactive bladder by administering a proprietary pre-programmed treatment protocol which provides electrical stimulation to the sacral nerve complex via the posterior tibial nerve. The treatment protocol produces in an inhibitory effect on bladder activity. A single treatment session lasts for 30 minutes of continuous neurostimulation. Repeated short duration stimulation incudes a persistent post-stimulation inhibitory effect.

Description of Medical Condition

Overactive Bladder is characterized by the presence of a number of symptoms affecting urinary control. Overactive Bladder is defined as urinary urgency with or without urgency urinary incontinence, usually with urinary frequency and nocturia. The hallmark symptom of Overactive Bladder is urinary urgency, which is defined as the sudden compelling desire to urinate that is difficult to defer. The symptom of urinary frequency is defined by an above average number of urination episodes while awake. Up to seven micturition episodes during waking hours is considered normal, however this will vary on a case-by-case basis depending on a number of factors such as hours spent awake and daily fluid intake. The symptom of nocturia is defined by the interruption of sleep due to the need to urinate. The symptom of urgency urinary incontinence is defined by a sudden compelling desire to urinate accompanied by the involuntary leakage of urine.

Reason for Application

New MBS item

Medical Service Type

Therapeutic

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

Final Protocol (PDF 4551 KB)
Final Protocol (Word 840 KB)

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 106 KB)
Public Summary Document (Word 90 KB)

Meetings for this Application

PASC

13 - 14 August 2015

ESC

6 - 7 October 2016

MSAC

24 - 25 November 2016